Ocugen to Host Clinical Showcase in New York City : comparem

Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial...

Related Keywords

New York , United States , Times Square , Lejla Vajzovic , Tarun Upadhyay , Neena Haider , Shankar Musunuri , Harvard Medical School , Head Of Communications , Duke University School Of Medicine , University Of Miami , Ocugen Inc , Exchange Commission , Nasdaq , Clinical Showcase , Nasdaq Market Site , Associate Professor , Duke Vitreoretinal Fellowship Program , Duke Eye Center , Duke University School , Byron Lam , Endowed Chair , Harvard Medical , Tiffany Hamilton , Private Securities Litigation Reform Act , Nasdaq Ocgn , Ocugen , Ophthalmology , Iopharmaceutical , Gene Therapy , Retinitis Pigmentosa , Lindness Diseases ,